Skip to main contentSkip to footer content

Latest News

Diversity, Equity and Inclusion Research Grants Fund Eight New TTUHSC Initiatives

Eight teams within the TTUHSC community were chosen as recipients of research grants offered through the Office of DEI, in collaboration with the Office of Research and the Office of the Provost.

Kang Receives CPRIT Funding to Support West Texas Pharmacology Core

CPRIT recently awarded a five-year, $3.37 million grant to Min Kang, Pharm.D. The grant will support the West Texas Pharmacology Core laboratory at TTUHSC.

Collaborative Analysis Finds No Link Between COVID-19 Vaccines, Guillain Barre Syndrome

The collaborative team's study, “No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study,” was published in August 2022 by the journal Vaccine.

Study Shows Shaker Channel Mutation Differs Structurally from Human Potassium Channels

In a study led by Luis Cuello, Ph.D., and Alain J. Labro, Ph.D., the researchers investigated whether or not a known mutation (W434F) found within Shaker-IR channel functionally accelerates the C-type inactivation state.

Startups Begin Here! Four Startups Awarded $50,000 from TTUHSC President

The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.

Teaching an Old Drug New Tricks

Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.

Snail Fever Vaccine Reaches First Human Clinical Trial

A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.

Gene Sequencing an Important Tool in COVID-19 Battle

Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.

TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution

The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.

TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers

CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.

Bridging Academia and Industry to Advance Drone Technologies

Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.

Pharmacy Researchers Receive Patent for Chemical Probe

Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.

TTUHSC Researcher Receives NIH Grant to Study Vulnerabilities in Specific Cancer Types

The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.

TTUHSC Receives NIH Grant to Examine Impact of Vitamin A Depletion on Alzheimer’s Disease

To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.

Texas Tech University Health Sciences Center Researchers Achieve Global Recognition

The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.

TTUHSC’s Rahman Receives Grant Extension

In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).

TTUHSC’s Jansen Receives NIH Grant to Continue Study into Neurological Disorders

To continue her research, the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes for Health (NIH) recently awarded Michaela Jansen, Pharm.D., Ph.D., a four-year, $1.53 million grant.

NIH Awards Grant to TTUHSC Researcher

To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.

Tags